Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DRAXIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCDC173 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATM-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTXN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MPV17L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TUBB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LHFPL3-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BCAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP49 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALKBH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBAKDN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506127 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on